Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

New Applications of CRISPR/Cas9 System on Mutant DNA Detection.

A Simple, Cost-Effective, and Efficient Method for Screening CRISPR/Cas9 Mutants in Plants

A universal and sensitive gene mutation detection method based on CRISPR-Cas12a

Gene point mutation information translation and detection: Leveraging single base extension and CRISPR/Cas12a

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects

Detection of low-frequency mutations in clinical samples by increasing mutation abundance via the excision of wild-type sequences

A Triple-Mismatch Differentiating assay exploiting activation and trans cleavage of CRISPR-Cas12a for mutation detection with ultra specificity and sensitivity

Temperature-boosted PAM-less activation of CRISPR-Cas12a combined with selective inhibitors enhances detection of SNVs with VAFs below 0.01%

Hairpin-locker mediated CRISPR/Cas tandem system for ultrasensitive detection of DNA without pre-amplification

High-Fidelity Identification of Single Nucleotide Polymorphism by Type V CRISPR Systems

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

An Efficient CRISPR/Cas Cooperative Shearing Platform for Clinical Diagnostics Applications

CRISPR-Cas13a system: A novel tool for molecular diagnostics

Rapid in situ mutation detection in extracellular vesicle-DNA

Rapid mutation detection in extracellular vesicle-DNA

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Combination of a modified block PCR and endonuclease IV-based signal amplification system for ultra-sensitive detection of low-abundance point mutations.